Foreign Filing Licenses: Key Considerations, First Filing Requirements, Design Patent Unique Issues, Export Controls
Recording of a 90-minute premium CLE video webinar with Q&A
This CLE course will guide patent counsel on foreign filing restrictions and licenses. It will also review the export controls considerations and pitfalls in that process. The panel will discuss various countries with filing restrictions and requirements, including the U.S., China, India, and other countries. The panel will address unique issues that design patent applications face. The panel will also offer best practices for avoiding foreign filing mistakes.
Outline
- Foreign filing restrictions and requirements
- Overview
- Specific countries
- U.S.
- China
- India
- Other countries
- Design patent unique issues
- Export controls
- Best practices for avoiding foreign filing mistakes
Benefits
The panel will review these and other key issues:
- What are foreign filing restrictions and licenses?
- What rights does a foreign filing license provide?
- What constitutes "developed in China"? What are the consequences of failing to understand when a license is required for China?
Faculty
Tracy-Gene Durkin
Director
Sterne Kessler Goldstein & Fox
Ms. Durkin heads the firm’s Mechanical and Design Patent Group. With nearly 30 years of experience obtaining... | Read More
Ms. Durkin heads the firm’s Mechanical and Design Patent Group. With nearly 30 years of experience obtaining and enforcing IP rights, she has a deep understanding of utility and design patents, trademarks, and copyrights. Ms. Durkin has been an Adjunct Professor at George Mason University Law School and has spoken internationally on topics such as the interplay between design patents and trade dress, and protection of user interface and the user experience. She is currently a Vice Chair of the Industrial Designs Committee of IP Section of the ABA.
ClosePeter Jeydel
Of Counsel
Steptoe & Johnson
Mr. Jeydel focuses his practice on US export controls and economic sanctions, including counseling, compliance,... | Read More
Mr. Jeydel focuses his practice on US export controls and economic sanctions, including counseling, compliance, transactional advice, licensing and opinions, jurisdiction and classification assessments, disclosures, and enforcement actions. In addition, he assists clients in anti-corruption matters, including under the Foreign Corrupt Practices Act (FCPA), and has experience handling reviews and investigations by the Committee on Foreign Investment in the United States (CFIUS). Prior to joining the firm, he worked on Central Asia policy in the Office of the Secretary of Defense (OSD). At OSD, he focused on the war in Afghanistan, working with governments and private sector entities in the surrounding region, from the Persian Gulf to the Caucasus, to Russia and China, and in particular the former Soviet states of Central Asia and Pakistan.
CloseLisa L. Mueller, J.D., B.S.
Shareholder
Casimir Jones
For over 25 years, Ms. Mueller has provided strategic counsel on complex patent issues to clients in the... | Read More
For over 25 years, Ms. Mueller has provided strategic counsel on complex patent issues to clients in the pharmaceutical, biopharmaceutical, biotechnology, and chemistry sectors. She brings in-depth knowledge and extensive experience to her work, advising clients on the global patent protection, freedom to operate, and validity of blockbuster drugs they aim to produce and distribute. With a background in chemistry and biology, she provides advice on the full spectrum of global intellectual property portfolio management, including patent prosecution, opposition, and other post-grant proceedings, and diverse regulatory matters. Since 2001, she has worked closely with in-house legal departments of global pharmaceutical firms regarding their patent development and enforcement strategies. In this partnership, Ms. Mueller provides training to new in-house counsel. She meets with scientists and other business development to anticipate and resolve a wide array of problems, including navigation of FDA approval. A thought leader on pharmaceutical and biopharmaceutical patent law, Ms. Mueller frequently speaks to legal and industry groups and publishes widely.
Close